26. Jahrestagung der Gesellschaft für Arzneimittelanwendungsforschung und Arzneimittelepidemiologie (GAA)
Gesellschaft für Arzneimittelanwendungsforschung und Arzneimittelepidemiologie
21.11. - 22.11.2019, Bonn/Bad Godesberg
Abstracts
Meeting Abstract
(19gaa01)
[Volltext]
Hormones and dementia – pharmacoepidemiological analyses of German health insurance data
Hoffmann J, Gomm W, Weckbecker K, Hänisch B[Volltext]
Meeting Abstract
(19gaa02)
[Volltext]
Updated pocket guide for diagnosis and management of chronic obstructive pulmonary disease (COPD) at the University Hospital Jena
Farker K, Hartmann M, Kroegel C[Volltext]
Meeting Abstract
(19gaa03)
[Volltext]
SSRI co-medication with NOAC or vitamin K antagonist does not increase hospitalization for bleeding events. A retrospective nation-wide cohort study in Austria 2010–2015
Klopprogge S, Mittlböck M, Reichardt B, Wolzt M[Volltext]
Meeting Abstract
(19gaa04)
[Volltext]
Does magnesium supplementation benefit pregnancy? The LIFE Child pregnancy cohort
Bremer SUJ, Neininger MP, Bertsche A, Kiess W, Bertsche T[Volltext]
Meeting Abstract
(19gaa05)
[Volltext]
Prescribing of metamizole and opioids in Germany on a regional level in 2010
Jobski K, Hoffmann F, Bantel C, Dörks M[Volltext]
Meeting Abstract
(19gaa06)
[Volltext]
Zwischen Erlösung und Verdammnis – Versprechen und aktuelle Realität von artificial intelligence in Versorgungsforschung und -praxis
Meyer I[Volltext]
Meeting Abstract
(19gaa07)
[Volltext]
ARMIN – Influence of structured medication management on pharmacy loyalty
Waldleben V, Fuchs A[Volltext]
Meeting Abstract
(19gaa08)
[Volltext]
Medication management by clinical pharmacists in the “DemStepCare” innovation fund project – a prospective cluster randomized intervention study in patients with dementia
Kockläuner M, Mildner C, Krämer I[Volltext]
Meeting Abstract
(19gaa09)
[Volltext]
Pharmacotherapy of psychiatric inpatients with adjustment disorder – current status and changes between 2000 and 2016
Greiner T, Haack B, Toto S, Bleich S, Grohmann R, Heinze M, Schneider M[Volltext]
Meeting Abstract
(19gaa10)
[Volltext]
Cross-sector postgraduate interprofessional workshops as a preventive tool to avoid risks of polypharmacy in the elderly – 1. Feasibility? 2. Resonance? ...and a revelation
Wolf U[Volltext]
Meeting Abstract
(19gaa11)
[Volltext]
Safe sailing on a preventive course in gerontopharmacology and polypharmacy requires the hoisting of important presetting superior sails
Wolf U[Volltext]
Meeting Abstract
(19gaa12)
[Volltext]
Iatrogenic burden and components of so-called presbydysphagia? Health care research in oropharygeal dysphagia in the elderly analysing associated and drug related risk factors
Wolf U, Walter G, Wienke A, Gregor S[Volltext]
Meeting Abstract
(19gaa13)
[Volltext]
The influence of intervention complexity on barriers and facilitators in the implementation of professional pharmacy services – a systematic review
Möcker R, Terstegen T, Haefeli WE, Seidling H[Volltext]
Meeting Abstract
(19gaa14)
[Volltext]
Prescribing practice of proton pump inhibitors in nursing home residents – results of a secondary data analysis
Wegener M, Berg A, Fleischer S, Meyer G, Wolf U[Volltext]
Meeting Abstract
(19gaa15)
[Volltext]
Practical demonstrations of insulin administration to evaluate the emergency management of paediatric patients with type I diabetes mellitus
Eisenhofer S, Neininger MP, Bertsche A, Kiess W, Kapellen TM, Bertsche T[Volltext]
Meeting Abstract
(19gaa16)
[Volltext]
PRISCUS 2.0 – An update and expansion of the first German list of potentially inappropriate medications
Mann NK, Mathes T, Sönnichsen A, Niepraschk-von Dollen K, Pieper D, Thürmann PA[Volltext]
Meeting Abstract
(19gaa17)
[Volltext]
Multimorbidity and polypharmacy for patients with mental and behavioural disorders in outpatient treatment
Schuster F, Emcke T, Ostermann T[Volltext]
Meeting Abstract
(19gaa18)
[Volltext]
Multimorbidity and polypharmacy for diabetes patients using regional secondary data of the Statutory Health Insurance
Schuster R, Heidbreder M, Emcke T, Schuster M[Volltext]
Meeting Abstract
(19gaa19)
[Volltext]
Vaccination of children – Primary immunization according to official recommendations of STIKO
Lappe V, Schubert I, Grandt D[Volltext]
Meeting Abstract
(19gaa20)
[Volltext]
Needs assessment for an interprofessional academic program for medication safety
Thevissen J, Böhmer A, Al Ghaddioui R, Olejniczak K, Dartsch D, Hänisch B, Laven A, Mahler C, Paeschke N, Seidling H, Weltermann B, Woltersdorf R, Jaehde U[Volltext]
Meeting Abstract
(19gaa21)
[Volltext]
Development of basic approaches to artificial intelligence in pharmacotherapy
Rose O, Netz M, Bücker M[Volltext]
Meeting Abstract
(19gaa22)
[Volltext]
Developing and finalising a deprescribing manual
Bencheva V, Mann NK, Schmiedl S, Abraham J, Altiner A, Icks A, Mortsiefer A, Wiese B, Wilm S, COFRAIL study group[Volltext]
Meeting Abstract
(19gaa23)
[Volltext]
Prescribers’ compliance with SmPC recommendations for dabigatran, rivaroxaban, and apixaban – a European comparative drug utilization study
Schmiedl S, Rottenkolber M, Ibanez L, Sabate M, Ballarin E, Vidal X, Leon-Munoz L, Huerta C, Martin Merino E, Montero D, Gasse C, Anderson M, Asgaer M, De Bruin M, Gerlach R, Tauscher M, Souverein P, van den Ham R, Klungel O, Gardarsdottir H[Volltext]
